{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:53:58Z","timestamp":1789804438190,"version":"4.0.1"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY030575-01"],"award-info":[{"award-number":["R01 EY030575-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 EY030631-01"],"award-info":[{"award-number":["R21 EY030631-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["STTR1937931"],"award-info":[{"award-number":["STTR1937931"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s11892-021-01404-5","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T15:02:37Z","timestamp":1631113357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Association Between Diabetes, Diabetic Retinopathy, and Glaucoma"],"prefix":"10.1007","volume":"21","author":[{"given":"Yangjiani","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Elze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1763-9401","authenticated-orcid":false,"given":"Nazlee","family":"Zebardast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"issue":"11","key":"1404_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y Tham","year":"2014","unstructured":"Tham Y, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;121(11):2081\u201390. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013.","journal-title":"Ophthalmology"},{"issue":"1","key":"1404_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3892\/mmr.2018.9071","volume":"18","author":"HW Wang","year":"2018","unstructured":"Wang HW, et al. Research progress on human genes involved in the pathogenesis of glaucoma (Review). Mol Med Rep. 2018;18(1):656\u201374. https:\/\/doi.org\/10.3892\/mmr.2018.9071.","journal-title":"Mol Med Rep"},{"key":"1404_CR3","unstructured":"K, B. Who is at risk for glaucoma? American Academy of Ophthalmology. 2020. https:\/\/www.aao.org\/eye-health\/diseases\/glaucoma-risk. Accessed Jan 2021."},{"key":"1404_CR4","unstructured":"Glaucoma tables. National Eye Institute. 2020. https:\/\/www.nei.nih.gov\/learn-about-eye-health\/resources-for-health-educators\/eye-health-data-and-statistics\/glaucoma-data-and-statistics\/glaucoma-tables. Accessed Jan 2021."},{"issue":"4","key":"1404_CR5","first-page":"471","volume":"104","author":"AG Actis","year":"2013","unstructured":"Actis AG, et al. An internal medicine perspective review of risk factors for assessing and progression of primary open angle glaucoma. Minerva Med. 2013;104(4):471\u201385.","journal-title":"Minerva Med"},{"issue":"10","key":"1404_CR6","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268\u201379. https:\/\/doi.org\/10.1001\/archopht.120.10.1268.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"1404_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701\u201313. https:\/\/doi.org\/10.1001\/archopht.120.6.701. Discussion 829-30.","journal-title":"Arch Ophthalmol"},{"key":"1404_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01403-6","author":"R Terauchi","year":"2021","unstructured":"Terauchi R, et al. Seasonal fluctuation in intraocular pressure and its associated factors in primary open-angle glaucoma. Eye. 2021. https:\/\/doi.org\/10.1038\/s41433-021-01403-6.","journal-title":"Eye"},{"issue":"1","key":"1404_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ophtha.2014.07.051","volume":"122","author":"D Zhao","year":"2015","unstructured":"Zhao D, et al. Diabetes, fasting glucose, and the risk of glaucoma. Ophthalmology. 2015;122(1):72\u20138. https:\/\/doi.org\/10.1016\/j.ophtha.2014.07.051.","journal-title":"Ophthalmology"},{"issue":"10108","key":"1404_CR10","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","volume":"390","author":"JB Jonas","year":"2017","unstructured":"Jonas JB, et al. Glaucoma. Lancet. 2017;390(10108):2183\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(17)31469-1.","journal-title":"Lancet"},{"issue":"2","key":"1404_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ajo.2011.01.032","volume":"152","author":"F Topouzis","year":"2011","unstructured":"Topouzis F, et al. Risk factors for primary open-angle glaucoma and pseudoexfoliative glaucoma in the Thessaloniki Eye Study. Am J Ophthalmol. 2011;152(2):219-228.e1. https:\/\/doi.org\/10.1016\/j.ajo.2011.01.032.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1404_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1442-9071.2010.02455.x","volume":"39","author":"M Yanagi","year":"2011","unstructured":"Yanagi M, et al. Vascular risk factors in glaucoma: a review. Clin Experiment Ophthalmol. 2011;39(3):252\u20138. https:\/\/doi.org\/10.1111\/j.1442-9071.2010.02455.x.","journal-title":"Clin Experiment Ophthalmol"},{"issue":"2","key":"1404_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ophtha.2006.06.050","volume":"114","author":"L Xu","year":"2007","unstructured":"Xu L, et al. High myopia and glaucoma susceptibility. Ophthalmology. 2007;114(2):216\u201320. https:\/\/doi.org\/10.1016\/j.ophtha.2006.06.050.","journal-title":"Ophthalmology"},{"issue":"5","key":"1404_CR14","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.ajo.2008.05.048","volume":"146","author":"BA Francis","year":"2008","unstructured":"Francis BA, et al. Intraocular pressure, central corneal thickness, and prevalence of open-angle glaucoma: the Los Angeles Latino Eye Study. Am J Ophthalmol. 2008;146(5):741\u20136. https:\/\/doi.org\/10.1016\/j.ajo.2008.05.048.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1404_CR15","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1167\/iovs.06-0299","volume":"47","author":"AR Rudnicka","year":"2006","unstructured":"Rudnicka AR, et al. Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci. 2006;47(10):4254\u201361. https:\/\/doi.org\/10.1167\/iovs.06-0299.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"1404_CR16","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.ophtha.2009.06.042","volume":"116","author":"A Heijl","year":"2009","unstructured":"Heijl A, et al. Natural History of Open-Angle Glaucoma. Ophthalmology. 2009;116(12):2271\u20136. https:\/\/doi.org\/10.1016\/j.ophtha.2009.06.042.","journal-title":"Ophthalmology"},{"issue":"2","key":"1404_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2020.21899","volume":"325","author":"JD Stein","year":"2021","unstructured":"Stein JD, Khawaja AP, Weizer JS. Glaucoma in adults\u2014screening, diagnosis, and management. JAMA. 2021;325(2):164. https:\/\/doi.org\/10.1001\/jama.2020.21899.","journal-title":"JAMA"},{"key":"1404_CR18","unstructured":"Weiner G. Meta-analysis confirms diabetes-glaucoma link. American Academy of Ophthalmology. 2015. https:\/\/www.aao.org\/eyenet\/article\/meta-analysis-confirms-diabetes-glaucoma-link. Accessed Jan 2021."},{"key":"1404_CR19","unstructured":"Diabetes facts and statistics. National Institute of Diabetes and Digestive and Kidney Diseases. 2020. https:\/\/www.niddk.nih.gov\/health-information\/health-statistics\/diabetes-statistics. Accessed Jan 2021."},{"issue":"5","key":"1404_CR20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2337\/dci18-0007","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917\u201328. https:\/\/doi.org\/10.2337\/dci18-0007.","journal-title":"Diabetes Care"},{"issue":"12","key":"1404_CR21","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.mpmed.2014.09.007","volume":"42","author":"NG Forouhi","year":"2014","unstructured":"Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine. 2014;42(12):698\u2013702. https:\/\/doi.org\/10.1016\/j.mpmed.2014.09.007.","journal-title":"Medicine"},{"key":"1404_CR22","unstructured":"Diabetic retinopathy tables. National Eye Institute. 2020. https:\/\/www.nei.nih.gov\/learn-about-eye-health\/resources-for-health-educators\/eye-health-data-and-statistics\/diabetic-retinopathy-data-and-statistics\/diabetic-retinopathy-tables. Accessed Jan 2021."},{"key":"1404_CR23","unstructured":"Prevention, C.F.D.C. Centers for disease control and prevention vision health initiative fact sheet: Diabetic retinopathy. Centers for Disease Control and Prevention. 2020. https:\/\/www.cdc.gov\/visionhealth\/pdf\/factsheet.pdf. Accessed Jan 2021."},{"issue":"2","key":"1404_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0002-9394(01)00844-3","volume":"131","author":"JD Ellis","year":"2000","unstructured":"Ellis JD, et al. Glaucoma incidence in an unselected cohort of diabetic patients: is diabetes mellitus a risk factor for glaucoma? Am J Ophthalmol. 2000;131(2):286. https:\/\/doi.org\/10.1016\/S0002-9394(01)00844-3.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1404_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0161-6420(95)31055-X","volume":"102","author":"JM Tielsch","year":"1995","unstructured":"Tielsch JM, et al. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology. 1995;102(1):48\u201353. https:\/\/doi.org\/10.1016\/S0161-6420(95)31055-X.","journal-title":"Ophthalmology"},{"issue":"1","key":"1404_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1076\/ceyr.28.1.47.23487","volume":"28","author":"A Kanamori","year":"2004","unstructured":"Kanamori A, et al. Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure. Curr Eye Res. 2004;28(1):47\u201354. https:\/\/doi.org\/10.1076\/ceyr.28.1.47.23487.","journal-title":"Curr Eye Res"},{"issue":"1","key":"1404_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000081775","volume":"219","author":"M Nakamura","year":"2005","unstructured":"Nakamura M, Kanamori A, Negi A. Diabetes mellitus as a risk factor for glaucomatous optic neuropathy. Ophthalmologica. 2005;219(1):1\u201310. https:\/\/doi.org\/10.1159\/000081775.","journal-title":"Ophthalmologica"},{"key":"1404_CR28","unstructured":"SS, H., Pathogenesis of optic nerve damage and visual field defects in glaucoma, in Docum Ophthal Proc Ser. 1980. p. 89\u2013110."},{"issue":"1","key":"1404_CR29","first-page":"170","volume":"43","author":"T Sato","year":"2002","unstructured":"Sato T, Roy S. Effect of high glucose on fibronectin expression and cell proliferation in trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2002;43(1):170\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1404_CR30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s12031-018-1188-x","volume":"66","author":"H Chakravarthy","year":"2018","unstructured":"Chakravarthy H, Devanathan V. Molecular mechanisms mediating diabetic retinal neurodegeneration: potential research avenues and therapeutic targets. J Mol Neurosci. 2018;66(3):445\u201361. https:\/\/doi.org\/10.1007\/s12031-018-1188-x.","journal-title":"J Mol Neurosci"},{"issue":"4","key":"1404_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.tjo.2016.05.009","volume":"6","author":"SS Ahmad","year":"2016","unstructured":"Ahmad SS. Controversies in the vascular theory of glaucomatous optic nerve degeneration. Taiwan J Ophthalmol. 2016;6(4):182\u20136. https:\/\/doi.org\/10.1016\/j.tjo.2016.05.009.","journal-title":"Taiwan J Ophthalmol"},{"issue":"5","key":"1404_CR32","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.preteyeres.2007.06.001","volume":"26","author":"SS Hayreh","year":"2007","unstructured":"Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007;26(5):470\u201385. https:\/\/doi.org\/10.1016\/j.preteyeres.2007.06.001.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"1404_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.4103\/ijo.IJO_1591_20","volume":"69","author":"S Senthil","year":"2021","unstructured":"Senthil S, et al. Neovascular glaucoma - a review. Indian J Ophthalmol. 2021;69(3):525\u201334. https:\/\/doi.org\/10.4103\/ijo.IJO_1591_20.","journal-title":"Indian J Ophthalmol"},{"issue":"12","key":"1404_CR34","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1001\/archopht.1980.01020041024003","volume":"98","author":"HA Kahn","year":"1980","unstructured":"Kahn HA. Alternative definitions of open-angle glaucoma: effect on prevalence and associations in the framingham eye study. Arch Ophthalmol. 1980;98(12):2172. https:\/\/doi.org\/10.1001\/archopht.1980.01020041024003.","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"1404_CR35","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0161-6420(94)31191-2","volume":"101","author":"BEK Klein","year":"1994","unstructured":"Klein BEK, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes: the Beaver Dam Eye Study. Ophthalmology. 1994;101(7):1173\u20137. https:\/\/doi.org\/10.1016\/S0161-6420(94)31191-2.","journal-title":"Ophthalmology"},{"key":"1404_CR36","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/s0161-6420(97)30247-4","volume":"104","author":"P Mitchell","year":"1997","unstructured":"Mitchell P, et al. Open-angle glaucoma and diabetes: the Blue Mountains Eye Study. Ophthalmology. 1997;104:712\u20138. https:\/\/doi.org\/10.1016\/s0161-6420(97)30247-4.","journal-title":"Ophthalmology"},{"issue":"12","key":"1404_CR37","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1001\/archopht.119.12.1819","volume":"119","author":"H Quigley","year":"2001","unstructured":"Quigley H, et al. The prevalence of glaucoma in a population-based study of hispanic subjects. Arch Ophthalmol. 2001;119(12):1819. https:\/\/doi.org\/10.1001\/archopht.119.12.1819.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"1404_CR38","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1167\/iovs.03-0077","volume":"44","author":"A Le","year":"2003","unstructured":"Le A, et al. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci. 2003;44(9):3783. https:\/\/doi.org\/10.1167\/iovs.03-0077.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"1404_CR39","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/j.ophtha.2006.03.063","volume":"113","author":"S de Voogd","year":"2006","unstructured":"de Voogd S, et al. Is diabetes mellitus a risk factor for open-angle glaucoma? The Rotterdam study. Ophthalmology. 2006;113(10):1827\u201331. https:\/\/doi.org\/10.1016\/j.ophtha.2006.03.063.","journal-title":"Ophthalmology"},{"issue":"9","key":"1404_CR40","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.ophtha.2006.03.059","volume":"113","author":"Y Suzuki","year":"2006","unstructured":"Suzuki Y, et al. Risk factors for open-angle glaucoma in a japanese population: the tajimi study. Ophthalmology. 2006;113(9):1613\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2006.03.059.","journal-title":"Ophthalmology"},{"issue":"7","key":"1404_CR41","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.ophtha.2006.01.066","volume":"113","author":"LR Pasquale","year":"2006","unstructured":"Pasquale LR, et al. Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology. 2006;113(7):1081\u20136. https:\/\/doi.org\/10.1016\/j.ophtha.2006.01.066.","journal-title":"Ophthalmology"},{"issue":"2","key":"1404_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3129\/canjophthalmol.i07-001","volume":"42","author":"AV Perruccio","year":"2007","unstructured":"Perruccio AV, Badley EM, Trope GE. Self-reported glaucoma in Canada: findings from population-based surveys, 1994\u20132003. Can J Ophthalmol. 2007;42(2):219\u201326. https:\/\/doi.org\/10.3129\/canjophthalmol.i07-001.","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"1404_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ophtha.2007.04.049","volume":"115","author":"V Chopra","year":"2008","unstructured":"Chopra V, et al. Type 2 diabetes mellitus and the risk of open-angle glaucoma: the Los Angeles Latino Eye Study. Ophthalmology. 2008;115(2):227-232.e1. https:\/\/doi.org\/10.1016\/j.ophtha.2007.04.049.","journal-title":"Ophthalmology"},{"issue":"1","key":"1404_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ophtha.2007.03.017","volume":"115","author":"MC Leske","year":"2008","unstructured":"Leske MC, et al. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008;115(1):85\u201393. https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.017.","journal-title":"Ophthalmology"},{"issue":"10","key":"1404_CR45","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/archophthalmol.2009.268","volume":"127","author":"GS Tan","year":"2009","unstructured":"Tan GS, et al. Diabetes, metabolic abnormalities, and glaucoma: the Singapore Malay Eye Study. Arch Ophthalmol. 2009;127(10):1354\u201361. https:\/\/doi.org\/10.1001\/archophthalmol.2009.268.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"1404_CR46","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.ajo.2010.06.037","volume":"150","author":"YX Wang","year":"2010","unstructured":"Wang YX, et al. Prevalence of glaucoma in North China: the Beijing Eye Study. Am J Ophthalmol. 2010;150(6):917\u201324. https:\/\/doi.org\/10.1016\/j.ajo.2010.06.037.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"1404_CR47","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.annepidem.2011.03.006","volume":"21","author":"LA Wise","year":"2011","unstructured":"Wise LA, et al. A prospective study of diabetes, lifestyle factors, and glaucoma among African-American women. Ann Epidemiol. 2011;21(6):430\u20139. https:\/\/doi.org\/10.1016\/j.annepidem.2011.03.006.","journal-title":"Ann Epidemiol"},{"issue":"7","key":"1404_CR48","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ophtha.2014.01.014","volume":"121","author":"L Vijaya","year":"2014","unstructured":"Vijaya L, et al. Predictors for incidence of primary open-angle glaucoma in a South Indian population. Ophthalmology. 2014;121(7):1370\u20136. https:\/\/doi.org\/10.1016\/j.ophtha.2014.01.014.","journal-title":"Ophthalmology"},{"issue":"8","key":"1404_CR49","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.ophtha.2014.03.003","volume":"121","author":"S Yamamoto","year":"2014","unstructured":"Yamamoto S, et al. Primary open-angle glaucoma in a population associated with high prevalence of primary angle-closure glaucoma. Ophthalmology. 2014;121(8):1558\u201365. https:\/\/doi.org\/10.1016\/j.ophtha.2014.03.003.","journal-title":"Ophthalmology"},{"issue":"11","key":"1404_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112460","volume":"9","author":"D Zhao","year":"2014","unstructured":"Zhao D, et al. Diabetes, glucose metabolism, and glaucoma: the 2005\u20132008 National Health and Nutrition Examination Survey. PLoS ONE. 2014;9(11): e112460. https:\/\/doi.org\/10.1371\/journal.pone.0112460.","journal-title":"PLoS ONE"},{"key":"1404_CR51","doi-asserted-by":"publisher","unstructured":"Kim MJ, et al. Risk factors for open-angle glaucoma with normal baseline intraocular pressure in a young population: the Korea National Health and Nutrition Examination Survey. Clin Exp Ophthalmol. 2014;42(9):825\u201332.\u00a0https:\/\/doi.org\/10.1111\/ceo.12347.","DOI":"10.1111\/ceo.12347"},{"issue":"4","key":"1404_CR52","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1167\/iovs.15-18373","volume":"57","author":"F Ko","year":"2016","unstructured":"Ko F, et al. Diabetes, triglyceride levels, and other risk factors for glaucoma in the national health and nutrition examination survey 2005\u20132008. Invest Opthalmol Vis Sci. 2016;57(4):2152. https:\/\/doi.org\/10.1167\/iovs.15-18373.","journal-title":"Invest Opthalmol Vis Sci"},{"key":"1404_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/2684674","volume":"2016","author":"A Horwitz","year":"2016","unstructured":"Horwitz A, et al. Danish Nationwide data reveal a link between diabetes mellitus, diabetic retinopathy, and glaucoma. J Diabetes Res. 2016;2016:1\u201310. https:\/\/doi.org\/10.1155\/2016\/2684674.","journal-title":"J Diabetes Res"},{"issue":"4","key":"1404_CR54","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.diabet.2017.09.007","volume":"44","author":"Y Jung","year":"2017","unstructured":"Jung Y, et al. Type 2 diabetes mellitus and risk of open-angle glaucoma development in Koreans: An 11-year nationwide propensity-score-matched study. Diabetes Metab. 2017;44(4):328\u201332. https:\/\/doi.org\/10.1016\/j.diabet.2017.09.007.","journal-title":"Diabetes Metab"},{"issue":"8","key":"1404_CR55","doi-asserted-by":"publisher","first-page":"e1025","DOI":"10.1111\/aos.13805","volume":"96","author":"TH Rim","year":"2018","unstructured":"Rim TH, et al. Increased risk of open-angle glaucoma among patients with diabetes mellitus: a 10-year follow-up nationwide cohort study. Acta Ophthalmol. 2018;96(8):e1025\u201330. https:\/\/doi.org\/10.1111\/aos.13805.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"1404_CR56","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/IJG.0000000000000138","volume":"25","author":"RA Gangwani","year":"2016","unstructured":"Gangwani RA, et al. Detection of glaucoma and its association with diabetic retinopathy in a diabetic retinopathy screening program. J Glaucoma. 2016;25(1):101\u20135. https:\/\/doi.org\/10.1097\/IJG.0000000000000138.","journal-title":"J Glaucoma"},{"issue":"1","key":"1404_CR57","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1186\/s12889-019-6935-6","volume":"19","author":"D Kreft","year":"2019","unstructured":"Kreft D, et al. Prevalence, incidence, and risk factors of primary open-angle glaucoma - a cohort study based on longitudinal data from a German public health insurance. BMC Public Health. 2019;19(1):851. https:\/\/doi.org\/10.1186\/s12889-019-6935-6.","journal-title":"BMC Public Health"},{"issue":"7","key":"1404_CR58","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.ophtha.2010.11.022","volume":"118","author":"PA Newman-Casey","year":"2011","unstructured":"Newman-Casey PA, et al. The relationship between components of metabolic syndrome and open-angle glaucoma. Ophthalmology. 2011;118(7):1318\u201326. https:\/\/doi.org\/10.1016\/j.ophtha.2010.11.022.","journal-title":"Ophthalmology"},{"issue":"8","key":"1404_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102972","volume":"9","author":"M Zhou","year":"2014","unstructured":"Zhou M, et al. Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. PLoS ONE. 2014;9(8): e102972. https:\/\/doi.org\/10.1371\/journal.pone.0102972.","journal-title":"PLoS ONE"},{"issue":"9","key":"1404_CR60","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.18240\/ijo.2017.09.16","volume":"10","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Chen X. Diabetes and risk of glaucoma: systematic review and a Meta-analysis of prospective cohort studies. Int J Ophthalmol. 2017;10(9):1430\u20135. https:\/\/doi.org\/10.18240\/ijo.2017.09.16.","journal-title":"Int J Ophthalmol"},{"issue":"6","key":"1404_CR61","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1464-5491.2004.01173.x","volume":"21","author":"S Bonovas","year":"2004","unstructured":"Bonovas S, Peponis V, Filioussi K. Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis. Diabet Med. 2004;21(6):609\u201314. https:\/\/doi.org\/10.1111\/j.1464-5491.2004.01173.x.","journal-title":"Diabet Med"},{"issue":"7","key":"1404_CR62","doi-asserted-by":"publisher","first-page":"e662","DOI":"10.1111\/aos.13345","volume":"95","author":"SW Kim","year":"2017","unstructured":"Kim SW, Kang GW. Diabetes mellitus as a risk factor for glaucoma outcome in Korea. Acta Ophthalmol. 2017;95(7):e662\u20134. https:\/\/doi.org\/10.1111\/aos.13345.","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"1404_CR63","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/jcm9030761","volume":"9","author":"A Grzybowski","year":"2020","unstructured":"\u2022 Grzybowski A, et al. Primary Open angle glaucoma and vascular risk factors: a review of population based studies from 1990 to 2019. J Clin Med. 2020;9(3):761. https:\/\/doi.org\/10.3390\/jcm9030761. Description: A recent meta-analysis study about the association between diabetes and POAG. The author reported a positive association between diabetes and increased IOP (but not POAG) based on population-based studies.","journal-title":"J Clin Med"},{"issue":"3","key":"1404_CR64","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/sj.eye.6703104","volume":"23","author":"L Xu","year":"2009","unstructured":"Xu L, et al. Ocular and systemic factors associated with diabetes mellitus in the adult population in rural and urban China. Beijing Eye Study Eye (Lond). 2009;23(3):676\u201382. https:\/\/doi.org\/10.1038\/sj.eye.6703104.","journal-title":"Beijing Eye Study Eye (Lond)"},{"issue":"1","key":"1404_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ceo.12763","volume":"45","author":"Y Tham","year":"2017","unstructured":"Tham Y, Cheng C. Associations between chronic systemic diseases and primary open angle glaucoma: an epidemiological perspective. Clin Experiment Ophthalmol. 2017;45(1):24\u201332. https:\/\/doi.org\/10.1111\/ceo.12763.","journal-title":"Clin Experiment Ophthalmol"},{"key":"1404_CR66","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2147\/DMSO.S160978","volume":"11","author":"A Khatri","year":"2018","unstructured":"Khatri A, et al. Severity of primary open-angle glaucoma in patients with hypertension and diabetes. Diabetes Metab Syndr Obes: Targets Ther. 2018;11:209\u201315. https:\/\/doi.org\/10.2147\/DMSO.S160978.","journal-title":"Diabetes Metab Syndr Obes: Targets Ther"},{"issue":"8","key":"1404_CR67","first-page":"2438","volume":"62","author":"Y Li","year":"2021","unstructured":"Li Y, et al. Age-controlled correlation between oral glucose tolerance test (OGTT) and thicknesses of ten retinal layers in non-diabetes and prediabetes participants from macular optical coherence tomography (OCT) volume scans. Invest Ophthalmol Vis Sci. 2021;62(8):2438.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1404_CR68","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/IJG.0000000000001745","volume":"30","author":"HL Rao","year":"2021","unstructured":"Rao HL, et al. Optical coherence tomography angiography and visual field progression in primary angle closure glaucoma. J Glaucoma. 2021;30(3):e61\u20137. https:\/\/doi.org\/10.1097\/IJG.0000000000001745.","journal-title":"J Glaucoma"},{"issue":"8","key":"1404_CR69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1167\/iovs.61.8.35","volume":"61","author":"K Lee","year":"2020","unstructured":"Lee K, et al. Risk Factors associated with structural progression in normal-tension glaucoma: intraocular pressure, systemic blood pressure, and myopia. Invest Opthalmol Vis Sci. 2020;61(8):35. https:\/\/doi.org\/10.1167\/iovs.61.8.35.","journal-title":"Invest Opthalmol Vis Sci"},{"issue":"2","key":"1404_CR70","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10792-020-01590-3","volume":"41","author":"FK Hassan","year":"2021","unstructured":"Hassan FK, et al. Optical coherence tomography indices for diagnosis of chronic glaucoma in patients with diabetes mellitus: a pilot study. Int Ophthalmol. 2021;41(2):409\u201320. https:\/\/doi.org\/10.1007\/s10792-020-01590-3.","journal-title":"Int Ophthalmol"},{"issue":"6","key":"1404_CR71","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/archopht.120.6.714","volume":"120","author":"MO Gordon","year":"2002","unstructured":"Gordon MO, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714\u201320. https:\/\/doi.org\/10.1001\/archopht.120.6.714. Discussion 829-30.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"1404_CR72","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/archophthalmol.2007.35","volume":"126","author":"MO Gordon","year":"2008","unstructured":"Gordon MO, Beiser JA, Kass MA. Is a history of diabetes mellitus protective against developing primary open-angle glaucoma? Arch Ophthalmol. 2008;126(2):280\u20131. https:\/\/doi.org\/10.1001\/archophthalmol.2007.35.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"1404_CR73","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ophtha.2014.11.015","volume":"122","author":"ES Charlson","year":"2015","unstructured":"Charlson ES, et al. The Primary Open-Angle African American Glaucoma Genetics study: baseline demographics. Ophthalmology. 2015;122(4):711\u201320. https:\/\/doi.org\/10.1016\/j.ophtha.2014.11.015.","journal-title":"Ophthalmology"},{"issue":"8","key":"1404_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218804","volume":"14","author":"N Khachatryan","year":"2019","unstructured":"Khachatryan N, et al. Primary Open-Angle African American Glaucoma Genetics (POAAGG) Study: gender and risk of POAG in African Americans. PLoS ONE. 2019;14(8): e0218804. https:\/\/doi.org\/10.1371\/journal.pone.0218804.","journal-title":"PLoS ONE"},{"issue":"1","key":"1404_CR75","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/IJG.0000000000000096","volume":"25","author":"S Akkaya","year":"2016","unstructured":"Akkaya S, Can E, \u00d6zt\u00fcrk F. Comparison of optic nerve head topographic parameters in patients with primary open-angle glaucoma with and without diabetes mellitus. J Glaucoma. 2016;25(1):49\u201353. https:\/\/doi.org\/10.1097\/IJG.0000000000000096.","journal-title":"J Glaucoma"},{"issue":"5","key":"1404_CR76","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10792-016-0191-x","volume":"36","author":"S Akkaya","year":"2016","unstructured":"Akkaya S, Can E, \u00d6zt\u00fcrk F. Comparison of the corneal biomechanical properties, optic nerve head topographic parameters, and retinal nerve fiber layer thickness measurements in diabetic and non-diabetic primary open-angle glaucoma. Int Ophthalmol. 2016;36(5):727\u201336. https:\/\/doi.org\/10.1007\/s10792-016-0191-x.","journal-title":"Int Ophthalmol"},{"issue":"1","key":"1404_CR77","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/aos.13848","volume":"97","author":"E Kosior-Jarecka","year":"2019","unstructured":"Kosior-Jarecka E, et al. Disc haemorrhages in Polish Caucasian patients with normal tension glaucoma. Acta Ophthalmol. 2019;97(1):68\u201373. https:\/\/doi.org\/10.1111\/aos.13848.","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"1404_CR78","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1007\/s10792-020-01507-0","volume":"40","author":"TM Abikoye","year":"2020","unstructured":"Abikoye TM, et al. Is primary open-angle glaucoma a risk factor for diabetic retinopathy? Int Ophthalmol. 2020;40(12):3233\u201340. https:\/\/doi.org\/10.1007\/s10792-020-01507-0.","journal-title":"Int Ophthalmol"},{"issue":"Suppl 1","key":"1404_CR79","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.4103\/ijo.IJO_1948_19","volume":"68","author":"UC Behera","year":"2020","unstructured":"Behera UC, et al. Spectrum of Eye Disease in Diabetes (SPEED) in India: a prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus. Indian J Ophthalmol. 2020;68(Suppl 1):S32\u20136. https:\/\/doi.org\/10.4103\/ijo.IJO_1948_19.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"1404_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211641","volume":"14","author":"YS Sim","year":"2019","unstructured":"Sim YS, et al. Increased prelaminar tissue thickness in patients with open-angle glaucoma and type 2 diabetes. PLoS ONE. 2019;14(2): e0211641. https:\/\/doi.org\/10.1371\/journal.pone.0211641.","journal-title":"PLoS ONE"},{"issue":"2","key":"1404_CR81","doi-asserted-by":"publisher","first-page":"268","DOI":"10.18240\/ijo.2019.02.13","volume":"12","author":"ZL Zhong","year":"2019","unstructured":"Zhong ZL, Chen S. Indicating and predicting role of the horizontal C\/D ratio in preclinical diabetic retinopathy associated with chronic angle-closure glaucoma. Int J Ophthalmol. 2019;12(2):268\u201374. https:\/\/doi.org\/10.18240\/ijo.2019.02.13.","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"1404_CR82","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010360","volume":"6","author":"H Yokomichi","year":"2016","unstructured":"Yokomichi H, et al. Evaluation of the associations between changes in intraocular pressure and metabolic syndrome parameters: a retrospective cohort study in Japan. BMJ Open. 2016;6(3): e010360. https:\/\/doi.org\/10.1136\/bmjopen-2015-010360.","journal-title":"BMJ Open"},{"issue":"9","key":"1404_CR83","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1136\/bjo.2007.128819","volume":"92","author":"K Kawase","year":"2008","unstructured":"Kawase K, et al. Ocular and systemic factors related to intraocular pressure in Japanese adults: the Tajimi study. Br J Ophthalmol. 2008;92(9):1175\u20139. https:\/\/doi.org\/10.1136\/bjo.2007.128819.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"1404_CR84","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/dmrr.529","volume":"21","author":"SW Oh","year":"2005","unstructured":"Oh SW, et al. Elevated intraocular pressure is associated with insulin resistance and metabolic syndrome. Diabetes Metab Res Rev. 2005;21(5):434\u201340. https:\/\/doi.org\/10.1002\/dmrr.529.","journal-title":"Diabetes Metab Res Rev"},{"issue":"7","key":"1404_CR85","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/IJG.0000000000000700","volume":"26","author":"E Cohen","year":"2017","unstructured":"Cohen E, et al. Relationship between serum glucose levels and intraocular pressure, a population-based cross-sectional study. J Glaucoma. 2017;26(7):652\u20136. https:\/\/doi.org\/10.1097\/IJG.0000000000000700.","journal-title":"J Glaucoma"},{"issue":"7","key":"1404_CR86","doi-asserted-by":"publisher","first-page":"824","DOI":"10.2337\/diab.44.7.824","volume":"44","author":"PJ Beisswenger","year":"1995","unstructured":"Beisswenger PJ, et al. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes. 1995;44(7):824\u20139. https:\/\/doi.org\/10.2337\/diab.44.7.824.","journal-title":"Diabetes"},{"issue":"1","key":"1404_CR87","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1167\/iovs.17-22316","volume":"59","author":"C Schweitzer","year":"2018","unstructured":"Schweitzer C, et al. Autofluorescence of skin advanced glycation end products as a risk factor for open angle glaucoma: the ALIENOR Study. Invest Ophthalmol Vis Sci. 2018;59(1):75\u201384. https:\/\/doi.org\/10.1167\/iovs.17-22316.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1404_CR88","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3341\/kjo.2012.26.2.123","volume":"26","author":"CH Park","year":"2012","unstructured":"Park CH, Kim JW. Effect of advanced glycation end products on oxidative stress and senescence of trabecular meshwork cells. Korean J Ophthalmol. 2012;26(2):123. https:\/\/doi.org\/10.3341\/kjo.2012.26.2.123.","journal-title":"Korean J Ophthalmol"},{"issue":"12","key":"1404_CR89","first-page":"2831","volume":"42","author":"JP Alexander","year":"2001","unstructured":"Alexander JP, Acott TS. Involvement of protein kinase C in TNF\u03b1 regulation of trabecular matrix metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci. 2001;42(12):2831\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1404_CR90","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0021-5155(01)00523-8","volume":"46","author":"Y Ochiai","year":"2002","unstructured":"Ochiai Y, Ochiai H. Higher concentration of transforming growth factor-\u03b2 in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn J Ophthalmol. 2002;46(3):249\u201353. https:\/\/doi.org\/10.1016\/S0021-5155(01)00523-8.","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"1404_CR91","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1167\/iovs.09-4567","volume":"51","author":"AR Shepard","year":"2010","unstructured":"Shepard AR, et al. Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes. Invest Ophthalmol Vis Sci. 2010;51(4):2067\u201376. https:\/\/doi.org\/10.1167\/iovs.09-4567.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1404_CR92","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000265311","volume":"16","author":"B Vojnikovic","year":"1984","unstructured":"Vojnikovic B. Hyperviscosity in whole blood, plasma, and aqueous humor decreased by doxium (calcium dobesilate) in diabetics with retinopathy and glaucoma: a double-blind controlled study. Ophthalmic Res. 1984;16(3):150\u201362. https:\/\/doi.org\/10.1159\/000265311.","journal-title":"Ophthalmic Res"},{"issue":"5","key":"1404_CR93","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1167\/iovs.17-23013","volume":"59","author":"X Luo","year":"2018","unstructured":"Luo X, et al. Direct and indirect associations between diabetes and intraocular pressure: the Singapore Epidemiology of Eye Diseases Study. Invest Ophthalmol Vis Sci. 2018;59(5):2205\u201311. https:\/\/doi.org\/10.1167\/iovs.17-23013.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"04","key":"1404_CR94","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4172\/2155-6156.1000364","volume":"05","author":"M Matteo Ciccone","year":"2014","unstructured":"Matteo Ciccone M. Endothelial function in pre-diabetes, diabetes and diabetic cardiomyopathy: a review. Journal of Diabetes & Metabolism. 2014;05(04):364. https:\/\/doi.org\/10.4172\/2155-6156.1000364.","journal-title":"Journal of Diabetes & Metabolism"},{"issue":"12","key":"1404_CR95","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1177\/1535370216654227","volume":"241","author":"B Brannick","year":"2016","unstructured":"Brannick B, Wynn A, Dagogo-Jack S. Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications. Exp Biol Med. 2016;241(12):1323\u201331. https:\/\/doi.org\/10.1177\/1535370216654227.","journal-title":"Exp Biol Med"},{"issue":"2","key":"1404_CR96","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1167\/iovs.10-5985","volume":"52","author":"Y Wang","year":"2011","unstructured":"Wang Y, et al. Pilot study of optical coherence tomography measurement of retinal blood flow in retinal and optic nerve diseases. Invest Ophthalmol Vis Sci. 2011;52(2):840\u20135. https:\/\/doi.org\/10.1167\/iovs.10-5985.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1404_CR97","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1167\/iovs.16-20531","volume":"58","author":"G Dimitrova","year":"2017","unstructured":"Dimitrova G, et al. Quantitative retinal optical coherence tomography angiography in patients with diabetes without diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58(1):190\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"1404_CR98","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1442-9071.2012.02778.x","volume":"40","author":"Y Shoshani","year":"2012","unstructured":"Shoshani Y, et al. Impaired ocular blood flow regulation in patients with open-angle glaucoma and diabetes. Clin Experiment Ophthalmol. 2012;40(7):697\u2013705. https:\/\/doi.org\/10.1111\/j.1442-9071.2012.02778.x.","journal-title":"Clin Experiment Ophthalmol"},{"issue":"4","key":"1404_CR99","doi-asserted-by":"publisher","first-page":"542","DOI":"10.5301\/ejo.5000419","volume":"24","author":"E Lee","year":"2014","unstructured":"Lee E, et al. The influence of retinal blood flow on open-angle glaucoma in patients with and without diabetes. Eur J Ophthalmol. 2014;24(4):542\u20139. https:\/\/doi.org\/10.5301\/ejo.5000419.","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"1404_CR100","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","volume":"21","author":"J Flammer","year":"2002","unstructured":"Flammer J, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21(4):359\u201393. https:\/\/doi.org\/10.1016\/S1350-9462(02)00008-3.","journal-title":"Prog Retin Eye Res"},{"key":"1404_CR101","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/864871","volume":"2015","author":"X Luo","year":"2015","unstructured":"Luo X, et al. Ocular blood flow autoregulation mechanisms and methods. J Ophthalmol. 2015;2015: 864871. https:\/\/doi.org\/10.1155\/2015\/864871.","journal-title":"J Ophthalmol"},{"issue":"3","key":"1404_CR102","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3129\/i08-057","volume":"43","author":"MR Lesk","year":"2008","unstructured":"Lesk MR, Wajszilber M, Deschenes MC. The effects of systemic medications on ocular blood flow. Can J Ophthalmol. 2008;43(3):351\u20135. https:\/\/doi.org\/10.3129\/i08-057.","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"1404_CR103","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/ijo.IJO_866_16","volume":"65","author":"M Nath","year":"2017","unstructured":"Nath M, Halder N, Velpandian T. Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy. Indian J Ophthalmol. 2017;65(3):191. https:\/\/doi.org\/10.4103\/ijo.IJO_866_16.","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"1404_CR104","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/s0008-4182(03)80051-0","volume":"38","author":"S Ozden","year":"2003","unstructured":"Ozden S, et al. Basal serum nitric oxide levels in patients with type 2 diabetes mellitus and different stages of retinopathy. Can J Ophthalmol. 2003;38(5):393\u20136. https:\/\/doi.org\/10.1016\/s0008-4182(03)80051-0.","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"1404_CR105","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10792-014-9979-8","volume":"35","author":"N L\u00f3pez-Riquelme","year":"2015","unstructured":"L\u00f3pez-Riquelme N, et al. Endothelin-1 levels and biomarkers of oxidative stress in glaucoma patients. Int Ophthalmol. 2015;35(4):527\u201332. https:\/\/doi.org\/10.1007\/s10792-014-9979-8.","journal-title":"Int Ophthalmol"},{"issue":"5","key":"1404_CR106","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1080\/10641963.2021.1896729","volume":"43","author":"R Rajendran","year":"2021","unstructured":"Rajendran R, et al. Assessment of vascular function in complete glycaemic spectrum. Clin Exp Hypertens. 2021;43(5):436\u201342. https:\/\/doi.org\/10.1080\/10641963.2021.1896729.","journal-title":"Clin Exp Hypertens"},{"issue":"4","key":"1404_CR107","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1167\/iovs.11-8420","volume":"53","author":"S Javadiyan","year":"2012","unstructured":"Javadiyan S, et al. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma. Invest Ophthalmol Vis Sci. 2012;53(4):1923\u20137. https:\/\/doi.org\/10.1167\/iovs.11-8420.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1404_CR108","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/354645","volume":"2010","author":"S Salvatore","year":"2010","unstructured":"Salvatore S, Vingolo EM. Endothelin-1 role in human eye: a review. J Ophthalmol. 2010;2010: 354645. https:\/\/doi.org\/10.1155\/2010\/354645.","journal-title":"J Ophthalmol"},{"issue":"7","key":"1404_CR109","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/eye.2009.108","volume":"23","author":"TM Curtis","year":"2009","unstructured":"Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond). 2009;23(7):1496\u2013508. https:\/\/doi.org\/10.1038\/eye.2009.108.","journal-title":"Eye (Lond)"},{"key":"1404_CR110","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.freeradbiomed.2021.01.040","volume":"165","author":"R Erkens","year":"2021","unstructured":"Erkens R, et al. Endothelium-dependent remote signaling in ischemia and reperfusion: Alterations in the cardiometabolic continuum. Free Radical Biol Med. 2021;165:265\u201381. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.01.040.","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"1404_CR111","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1038\/s41598-018-21198-z","volume":"8","author":"SS Chaurasia","year":"2018","unstructured":"Chaurasia SS, et al. The NLRP3 inflammasome may contribute to pathologic neovascularization in the advanced stages of diabetic retinopathy. Sci Rep. 2018;8(1):2847. https:\/\/doi.org\/10.1038\/s41598-018-21198-z.","journal-title":"Sci Rep"},{"issue":"30","key":"1404_CR112","doi-asserted-by":"publisher","first-page":"11181","DOI":"10.1073\/pnas.1402819111","volume":"111","author":"W Chi","year":"2014","unstructured":"Chi W, et al. Caspase-8 promotes NLRP1\/NLRP3 inflammasome activation and IL-1 beta production in acute glaucoma. Proc Natl Acad Sci. 2014;111(30):11181\u20136. https:\/\/doi.org\/10.1073\/pnas.1402819111.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"1404_CR113","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4239\/wjd.v5.i2.141","volume":"5","author":"T Sugiyama","year":"2014","unstructured":"Sugiyama T. Role of P2X7 receptors in the development of diabetic retinopathy. World J Diabetes. 2014;5(2):141. https:\/\/doi.org\/10.4239\/wjd.v5.i2.141.","journal-title":"World J Diabetes"},{"issue":"3","key":"1404_CR114","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1167\/iovs.12-10968","volume":"54","author":"N Niyadurupola","year":"2013","unstructured":"Niyadurupola N, et al. P2X7 receptor activation mediates retinal ganglion cell death in a human retina model of ischemic neurodegeneration. Invest Ophthalmol Vis Sci. 2013;54(3):2163\u201370. https:\/\/doi.org\/10.1167\/iovs.12-10968.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1404_CR115","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1165\/rcmb.2011-0247OC","volume":"46","author":"DJ LaPar","year":"2012","unstructured":"LaPar DJ, et al. Acute hyperglycemic exacerbation of lung ischemia\u2013reperfusion injury is mediated by receptor for advanced glycation end-products signaling. Am J Respir Cell Mol Biol. 2012;46(3):299\u2013305. https:\/\/doi.org\/10.1165\/rcmb.2011-0247OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"1404_CR116","doi-asserted-by":"publisher","first-page":"BIO227","DOI":"10.1167\/iovs.17-21776","volume":"58","author":"E Stefansson","year":"2017","unstructured":"Stefansson E, et al. Retinal oximetry discovers novel biomarkers in retinal and brain diseases. Invest Ophthalmol Vis Sci. 2017;58(6):BIO227\u201333. https:\/\/doi.org\/10.1167\/iovs.17-21776.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1404_CR117","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3389\/fphar.2020.01063","volume":"11","author":"F Lazzara","year":"2020","unstructured":"Lazzara F, et al. Stabilization of HIF-1\u03b1 in Human retinal endothelial cells modulates expression of mirnas and proangiogenic growth factors. Front Pharmacol. 2020;11:1063. https:\/\/doi.org\/10.3389\/fphar.2020.01063.","journal-title":"Front Pharmacol"},{"issue":"9","key":"1404_CR118","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1001\/archopht.122.9.1348","volume":"122","author":"G Tezel","year":"2004","unstructured":"Tezel G, Wax MB. Hypoxia-inducible factor 1alpha in the glaucomatous retina and optic nerve head. Arch Ophthalmol. 2004;122(9):1348\u201356. https:\/\/doi.org\/10.1001\/archopht.122.9.1348.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"1404_CR119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153354","volume":"11","author":"F McDonnell","year":"2016","unstructured":"McDonnell F, et al. Hypoxia-Induced Changes in DNA Methylation Alter RASAL1 and TGF\u03b21 Expression in Human Trabecular Meshwork Cells. PLoS ONE. 2016;11(4): e0153354. https:\/\/doi.org\/10.1371\/journal.pone.0153354.","journal-title":"PLoS ONE"},{"issue":"1","key":"1404_CR120","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10384-013-0267-3","volume":"58","author":"E Chihara","year":"2014","unstructured":"Chihara E. Myopia and diabetes mellitus as modificatory factors of glaucomatous optic neuropathy. Jpn J Ophthalmol. 2014;58(1):16\u201325. https:\/\/doi.org\/10.1007\/s10384-013-0267-3.","journal-title":"Jpn J Ophthalmol"},{"key":"1404_CR121","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1167\/iovs.16-19638","volume":"58","author":"EEB De Clerck","year":"2017","unstructured":"De Clerck EEB, et al. Loss of Temporal peripapillary retinal nerve fibers in prediabetes or type 2 diabetes without diabetic retinopathy: the Maastricht Study. Invest Ophthalmol Vis Sci. 2017;58:1017\u201327. https:\/\/doi.org\/10.1167\/iovs.16-19638.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"1404_CR122","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1167\/iovs.16-19525","volume":"57","author":"SJ Jeon","year":"2016","unstructured":"Jeon SJ, et al. Characteristics of Retinal Nerve Fiber Layer Defect in Nonglaucomatous Eyes With Type II Diabetes. Invest Ophthalmol Vis Sci. 2016;57(10):4008\u201315. https:\/\/doi.org\/10.1167\/iovs.16-19525.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"1404_CR123","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1111\/bph.15033","volume":"177","author":"KI Jung","year":"2020","unstructured":"\u2022 Jung KI, Woo JE, Park CK. Intraocular pressure fluctuation and neurodegeneration in the diabetic rat retina. Br J Pharmacol. 2020;177(13):3046\u201359. https:\/\/doi.org\/10.1111\/bph.15033. Description: This study provides evidence of gliosis, neuroinflammation, and neurodegeneration induces by experimental diabetes. Glaucoma medication can reduce those pathological damages and improve RGCs survival.","journal-title":"Br J Pharmacol"},{"issue":"13","key":"1404_CR124","doi-asserted-by":"publisher","first-page":"9316","DOI":"10.1167\/iovs.11-7879","volume":"52","author":"A Ly","year":"2011","unstructured":"Ly A, et al. Early inner retinal astrocyte dysfunction during diabetes and development of hypoxia, retinal stress, and neuronal functional loss. Invest Ophthalmol Vis Sci. 2011;52(13):9316\u201326. https:\/\/doi.org\/10.1167\/iovs.11-7879.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"1404_CR125","first-page":"1971","volume":"41","author":"E Rungger-Brandle","year":"2000","unstructured":"Rungger-Brandle E, Dosso AA, Leuenberger PM. Glial Reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2000;41(7):1971\u201380.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1404_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108498","volume":"187","author":"KD Rolev","year":"2021","unstructured":"Rolev KD, Shu X, Ying Y. Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy. Neuropharmacology. 2021;187: 108498. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108498.","journal-title":"Neuropharmacology"},{"issue":"4","key":"1404_CR127","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1172\/JCI2425","volume":"102","author":"AJ Barber","year":"1998","unstructured":"Barber AJ, et al. Neural apoptosis in the retina during experimental and human diabetes. J Clin Invest. 1998;102(4):783\u201391. https:\/\/doi.org\/10.1172\/JCI2425.","journal-title":"J Clin Invest"},{"issue":"10","key":"1404_CR128","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1167\/iovs.17-22242","volume":"58","author":"G Hondur","year":"2017","unstructured":"Hondur G, et al. Oxidative stress-related molecular biomarker candidates for glaucoma. Invest Ophthalmol Vis Sci. 2017;58(10):4078\u201388. https:\/\/doi.org\/10.1167\/iovs.17-22242.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1404_CR129","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000331990","volume":"47","author":"N Terai","year":"2012","unstructured":"Terai N, et al. Diabetes mellitus affects biomechanical properties of the optic nerve head in the rat. Ophthalmic Res. 2012;47(4):189\u201394. https:\/\/doi.org\/10.1159\/000331990.","journal-title":"Ophthalmic Res"},{"key":"1404_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.100773","volume":"74","author":"C Boote","year":"2020","unstructured":"Boote C, et al. Scleral structure and biomechanics. Prog Retin Eye Res. 2020;74: 100773. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.100773.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"1404_CR131","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.neuroscience.2010.06.021","volume":"169","author":"JM Gaspar","year":"2010","unstructured":"Gaspar JM, et al. Diabetes differentially affects the content of exocytotic proteins in hippocampal and retinal nerve terminals. Neuroscience. 2010;169(4):1589\u2013600. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.06.021.","journal-title":"Neuroscience"},{"issue":"9","key":"1404_CR132","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1167\/iovs.14-14371","volume":"55","author":"G Han","year":"2014","unstructured":"Han G, et al. The mitochondrial complex I inhibitor rotenone induces endoplasmic reticulum stress and activation of GSK-3beta in cultured rat retinal cells. Invest Ophthalmol Vis Sci. 2014;55(9):5616\u201328. https:\/\/doi.org\/10.1167\/iovs.14-14371.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"1404_CR133","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11892-016-0815-6","volume":"16","author":"BJ Song","year":"2016","unstructured":"\u2022 Song BJ, Aiello LP, Pasquale LR. Presence and risk factors for glaucoma in patients with diabetes. Curr DiabRep. 2016;16(12):124. https:\/\/doi.org\/10.1007\/s11892-016-0815-6. Description: This review summarized risk factors and epidemiological association for glaucoma in the population with diabetes.","journal-title":"Curr DiabRep"},{"key":"1404_CR134","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.exer.2014.07.011","volume":"127","author":"FI Baptista","year":"2014","unstructured":"Baptista FI, et al. Diabetes induces changes in KIF1A, KIF5B and dynein distribution in the rat retina: Implications for axonal transport. Exp Eye Res. 2014;127:91\u2013103. https:\/\/doi.org\/10.1016\/j.exer.2014.07.011.","journal-title":"Exp Eye Res"},{"issue":"2","key":"1404_CR135","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1076\/0271-3683(200002)2021-DFT131","volume":"20","author":"L Zhang","year":"2000","unstructured":"Zhang L, et al. Retrograde axonal transport impairment of large- and medium-sized retinal ganglion cells in diabetic rat. Curr Eye Res. 2000;20(2):131\u20136.","journal-title":"Curr Eye Res"},{"issue":"9","key":"1404_CR136","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.2337\/diabetes.53.9.2412","volume":"53","author":"M Seki","year":"2004","unstructured":"Seki M, et al. Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes. 2004;53(9):2412\u20139. https:\/\/doi.org\/10.2337\/diabetes.53.9.2412.","journal-title":"Diabetes"},{"issue":"3","key":"1404_CR137","first-page":"764","volume":"41","author":"ME Pease","year":"2000","unstructured":"Pease ME, et al. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci. 2000;41(3):764\u201374.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"1404_CR138","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/hmg\/ddy053","volume":"27","author":"Y Shiga","year":"2018","unstructured":"Shiga Y, et al. Genome-wide association study identifies seven novel susceptibility loci for primary open-angle glaucoma. Hum Mol Genet. 2018;27(8):1486\u201396. https:\/\/doi.org\/10.1093\/hmg\/ddy053.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1404_CR139","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41588-018-0047-6","volume":"50","author":"M Kanai","year":"2018","unstructured":"Kanai M, et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat Genet. 2018;50(3):390\u2013400. https:\/\/doi.org\/10.1038\/s41588-018-0047-6.","journal-title":"Nat Genet"},{"issue":"2","key":"1404_CR140","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/aje\/kwv204","volume":"183","author":"L Shen","year":"2015","unstructured":"Shen L, et al. Diabetes pathology and risk of primary open-angle glaucoma: evaluating causal mechanisms by using genetic information. Am J Epidemiol. 2015;183(2):147\u201355. https:\/\/doi.org\/10.1093\/aje\/kwv204.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"1404_CR141","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/1535370219842791","volume":"244","author":"Y Wang","year":"2019","unstructured":"Wang Y, et al. Interaction between XRCC 1 gene polymorphisms and diabetes on susceptibility to primary open-angle glaucoma. Exp Biol Med. 2019;244(7):588\u201392. https:\/\/doi.org\/10.1177\/1535370219842791.","journal-title":"Exp Biol Med"},{"key":"1404_CR142","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ajo.2019.05.015","volume":"206","author":"V Laville","year":"2019","unstructured":"Laville V, et al. Genetic correlations between diabetes and glaucoma: an analysis of continuous and dichotomous phenotypes. Am J Ophthalmol. 2019;206:245\u201355. https:\/\/doi.org\/10.1016\/j.ajo.2019.05.015.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1404_CR143","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1001\/archophthalmol.2011.269","volume":"129","author":"A Ebneter","year":"2011","unstructured":"Ebneter A, et al. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma. Arch Ophthalmol. 2011;129(10):1337\u201344. https:\/\/doi.org\/10.1001\/archophthalmol.2011.269.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"1404_CR144","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","volume":"171","author":"K Nishijima","year":"2007","unstructured":"Nishijima K, et al. Vascular endothelial growth factor-a is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol. 2007;171(1):53\u201367. https:\/\/doi.org\/10.2353\/ajpath.2007.061237.","journal-title":"Am J Pathol"},{"issue":"4","key":"1404_CR145","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.ajpath.2012.12.032","volume":"182","author":"RH Foxton","year":"2013","unstructured":"Foxton RH, et al. VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma. Am J Pathol. 2013;182(4):1379\u201390. https:\/\/doi.org\/10.1016\/j.ajpath.2012.12.032.","journal-title":"Am J Pathol"},{"issue":"3","key":"1404_CR146","doi-asserted-by":"publisher","first-page":"406","DOI":"10.20471\/acc.2017.56.03.07","volume":"56","author":"A Kopi\u0107","year":"2017","unstructured":"Kopi\u0107 A. Retinal nerve fiber layer thickness in glaucoma patients treated with multiple intravitreal anti-Vegf (bevacizumab) injections. Acta Clinica Croatica. 2017;56(3):406\u201314. https:\/\/doi.org\/10.20471\/acc.2017.56.03.07.","journal-title":"Acta Clinica Croatica"},{"issue":"2","key":"1404_CR147","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1001\/archophthalmol.2008.596","volume":"127","author":"HA Quigley","year":"2009","unstructured":"Quigley HA. Can diabetes be good for glaucoma? Why can\u2019t we believe our own eyes (or data)? Arch Ophthalmol (1960). 2009;127(2):222\u20139. https:\/\/doi.org\/10.1001\/archophthalmol.2008.596.","journal-title":"Arch Ophthalmol (1960)"},{"issue":"1","key":"1404_CR148","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1152\/physrev.00039.2006","volume":"88","author":"TP Obrenovitch","year":"2008","unstructured":"Obrenovitch TP. Molecular Physiology of preconditioning-induced brain tolerance to ischemia. Physiol Rev. 2008;88(1):211\u201347. https:\/\/doi.org\/10.1152\/physrev.00039.2006.","journal-title":"Physiol Rev"},{"key":"1404_CR149","first-page":"2360","volume":"19","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Zhang L, Gidday JM. Role of hypoxia-inducible factor-1alpha in preconditioning-induced protection of retinal ganglion cells in glaucoma. Mol Vis. 2013;19:2360\u201372.","journal-title":"Mol Vis"},{"key":"1404_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.109249","volume":"331","author":"H Chen","year":"2020","unstructured":"Chen H, et al. TGF-\u03b21 signaling protects retinal ganglion cells from oxidative stress via modulation of the HO-1\/Nrf2 pathway. Chem Biol Interact. 2020;331: 109249. https:\/\/doi.org\/10.1016\/j.cbi.2020.109249.","journal-title":"Chem Biol Interact"},{"issue":"Supplement 1","key":"1404_CR151","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.2337\/dc21-S011","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes\u20142021. Diabetes Care. 2021;44(Supplement 1):S151\u201367. https:\/\/doi.org\/10.2337\/dc21-S011.","journal-title":"Diabetes Care"},{"issue":"3","key":"1404_CR152","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jamaophthalmol.2015.5605","volume":"134","author":"PS Silva","year":"2016","unstructured":"Silva PS, et al. Comparison of nondiabetic retinal findings identified with nonmydriatic fundus photography vs ultrawide field imaging in an ocular Telehealth program. JAMA Ophthalmol. 2016;134(3):330\u20134. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.5605.","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"1404_CR153","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1167\/iovs.16-19457R1","volume":"57","author":"SY Jeong","year":"2016","unstructured":"Jeong SY, et al. Spectral-domain optical coherence tomography features in open-angle glaucoma with diabetes mellitus and inadequate glycemic control. Invest Opthalmol Vis Sci. 2016;57(7):3024. https:\/\/doi.org\/10.1167\/iovs.16-19457R1.","journal-title":"Invest Opthalmol Vis Sci"},{"issue":"11","key":"1404_CR154","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1167\/iovs.09-5060","volume":"51","author":"Y Zheng","year":"2010","unstructured":"Zheng Y, et al. Influence of diabetes and diabetic retinopathy on the performance of Heidelberg retina tomography II for diagnosis of glaucoma. Invest Ophthalmol Vis Sci. 2010;51(11):5519\u201324. https:\/\/doi.org\/10.1167\/iovs.09-5060.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"1404_CR155","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/IJG.0b013e3182447d58","volume":"22","author":"HS Ong","year":"2013","unstructured":"Ong HS, Levin S, Vafidis G. Glaucoma detection using optic disc images from the English National Screening Programme for Diabetic Retinopathy. J Glaucoma. 2013;22(6):496\u2013500. https:\/\/doi.org\/10.1097\/IJG.0b013e3182447d58.","journal-title":"J Glaucoma"},{"key":"1404_CR156","doi-asserted-by":"publisher","first-page":"3879651","DOI":"10.1155\/2019\/3879651","volume":"2019","author":"L Ramm","year":"2019","unstructured":"Ramm L, et al. Intraocular pressure measurement using ocular response analyzer, dynamic contour tonometer, and scheimpflug analyzer Corvis ST. J Ophthalmol. 2019;2019:3879651. https:\/\/doi.org\/10.1155\/2019\/3879651.","journal-title":"J Ophthalmol"},{"issue":"1","key":"1404_CR157","first-page":"61","volume":"9","author":"Y Bilong","year":"2020","unstructured":"Bilong Y, et al. Smartphone-assisted glaucoma screening in patients with type 2 diabetes: a pilot study. Med Hypothesis Discov Innov Ophthalmol. 2020;9(1):61\u20135.","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"1404_CR158","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmpb.2017.11.013","volume":"154","author":"N Anton Apreutesei","year":"2018","unstructured":"Anton Apreutesei N, et al. Predictions of ocular changes caused by diabetes in glaucoma patients. Comput Methods Programs Biomed. 2018;154:183\u201390. https:\/\/doi.org\/10.1016\/j.cmpb.2017.11.013.","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"1404_CR159","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2014-000031","volume":"2","author":"DJ Lee","year":"2014","unstructured":"Lee DJ, et al. Dilated eye examination screening guideline compliance among patients with diabetes without a diabetic retinopathy diagnosis: the role of geographic access. BMJ Open Diabetes Res Care. 2014;2(1): e000031. https:\/\/doi.org\/10.1136\/bmjdrc-2014-000031.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"21","key":"1404_CR160","doi-asserted-by":"publisher","first-page":"00033","DOI":"10.1016\/j.ogla.2021.01.005","volume":"S2589\u20134196","author":"R Ayub","year":"2021","unstructured":"Ayub R, et al. Outcomes and reasons for late presentation of lens induced glaucoma. Ophthalmol Glaucoma. 2021;S2589\u20134196(21):00033\u20138. https:\/\/doi.org\/10.1016\/j.ogla.2021.01.005.","journal-title":"Ophthalmol Glaucoma"},{"issue":"9","key":"1404_CR161","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/ceo.13838","volume":"48","author":"W Mitchell","year":"2020","unstructured":"Mitchell W, Hassall M, Henderson T. Updating the model of eye care for Aboriginal populations in remote Central Australia. Clin Exp Ophthalmol. 2020;48(9):1299\u2013306. https:\/\/doi.org\/10.1111\/ceo.13838.","journal-title":"Clin Exp Ophthalmol"},{"key":"1404_CR162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2018.02.002","volume":"189","author":"H Hou","year":"2018","unstructured":"Hou H, et al. Progression of Primary open-angle glaucoma in diabetic and nondiabetic patients. Am J Ophthalmol. 2018;189:1\u20139. https:\/\/doi.org\/10.1016\/j.ajo.2018.02.002.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"1404_CR163","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaophthalmol.2015.1440","volume":"133","author":"H Lin","year":"2015","unstructured":"Lin H, et al. Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons with Diabetes Mellitus. JAMA Ophthalmology. 2015;133(8):915. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.1440.","journal-title":"JAMA Ophthalmology"},{"issue":"3","key":"1404_CR164","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbrc.2017.08.087","volume":"492","author":"YS Kim","year":"2017","unstructured":"Kim YS, et al. Metformin protects against retinal cell death in diabetic mice. Biochem Biophys Res Commun. 2017;492(3):397\u2013403. https:\/\/doi.org\/10.1016\/j.bbrc.2017.08.087.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1404_CR165","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0002-9394(02)01658-6","volume":"134","author":"AGIS Investigators","year":"2002","unstructured":"Investigators AGIS. The advanced glaucoma intervention study (AGIS): 11. risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol. 2002;134(4):481\u201398. https:\/\/doi.org\/10.1016\/S0002-9394(02)01658-6.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1404_CR166","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0002-9394(02)01659-8","volume":"134","author":"AGIS Investigators","year":"2002","unstructured":"Investigators AGIS. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol. 2002;134(4):499\u2013512. https:\/\/doi.org\/10.1016\/S0002-9394(02)01659-8.","journal-title":"Am J Ophthalmol"},{"key":"1404_CR167","doi-asserted-by":"publisher","first-page":"7947854","DOI":"10.1155\/2017\/7947854","volume":"2017","author":"J Liu","year":"2017","unstructured":"Liu J, et al. Long-term outcomes of primary trabeculectomy in diabetic patients without retinopathy with primary angle-closure glaucoma. J Ophthalmol. 2017;2017:7947854. https:\/\/doi.org\/10.1155\/2017\/7947854.","journal-title":"J Ophthalmol"},{"issue":"2","key":"1404_CR168","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","volume":"116","author":"DC Musch","year":"2009","unstructured":"Musch DC, et al. Visual field progression in the collaborative initial glaucoma treatment study. Ophthalmology. 2009;116(2):200-207.e1. https:\/\/doi.org\/10.1016\/j.ophtha.2008.08.051.","journal-title":"Ophthalmology"},{"issue":"5","key":"1404_CR169","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1136\/bjophthalmol-2012-302227","volume":"97","author":"SK Law","year":"2013","unstructured":"Law SK, et al. Long-term outcomes of primary trabeculectomy in diabetic patients with primary open angle glaucoma. Br J Ophthalmol. 2013;97(5):561\u20136. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-302227.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"1404_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/eye.2013.234","volume":"28","author":"C Mariotti","year":"2014","unstructured":"Mariotti C, et al. Long-term outcomes and risk factors for failure with the EX-press glaucoma drainage device. Eye. 2014;28(1):1\u20138. https:\/\/doi.org\/10.1038\/eye.2013.234.","journal-title":"Eye"},{"issue":"6","key":"1404_CR171","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/IJG.0b013e3181f3e5b4","volume":"22","author":"SM Huddleston","year":"2013","unstructured":"Huddleston SM, et al. Aqueous Shunt Exposure. J Glaucoma. 2013;22(6):433\u20138. https:\/\/doi.org\/10.1097\/IJG.0b013e3181f3e5b4.","journal-title":"J Glaucoma"},{"issue":"3","key":"1404_CR172","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1067-1927.2005.00130312.x","volume":"13","author":"AC Browning","year":"2005","unstructured":"Browning AC, et al. Effect of diabetes mellitus and hyperglycemia on the proliferation of human Tenon\u2019s capsule fibroblasts: implications for wound healing after glaucoma drainage surgery. Wound Repair Regen. 2005;13(3):295\u2013302. https:\/\/doi.org\/10.1111\/j.1067-1927.2005.00130312.x.","journal-title":"Wound Repair Regen"},{"issue":"1","key":"1404_CR173","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1076\/ceyr.27.2.35.15456","volume":"27","author":"PO Denk","year":"2003","unstructured":"Denk PO, et al. Effect of growth factors on the activation of human Tenon\u2019s capsule fibroblasts. Curr Eye Res. 2003;27(1):35\u201344. https:\/\/doi.org\/10.1076\/ceyr.27.2.35.15456.","journal-title":"Curr Eye Res"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-021-01404-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11892-021-01404-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-021-01404-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T14:06:23Z","timestamp":1636293983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11892-021-01404-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":173,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1007\/s11892-021-01404-5","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"assertion":[{"value":"19 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"All authors have no relevant employment information to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"38"}}